Earnings Analyzer
Stock earnings page

MeiraGTx Holdings plc (MGTX)

Track the next or latest earnings date for MeiraGTx Holdings plc, review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

MeiraGTx: The Market Is Missing The Manufacturing Pivot (NASDAQ:MGTX) | Seeking Alpha
seekingalpha.com · 1 week ago

MeiraGTx is evolving into a late-stage, manufacturing-enabled genetic medicine company with multiple near-term regulatory catalysts. Learn more about MGTX stock here.

Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint
finance.yahoo.com · May 20, 2026

MeiraGTx Holdings PLC (NASDAQ:MGTX) is one of the best gene therapy stocks to buy in 2026. The stock has gained around 25% year-to-date and soared more than 95% over the past year. Looking ahead, analysts believe the stock could explode more than 100% in the next 12 months as MeiraGTx advances ...

MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock?
finance.yahoo.com · April 20, 2026

MeiraGTx (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

MeiraGTx Holdings stock hits 52-week high at 13.72 USD By Investing.com
ca.investing.com · 5 days ago

According to InvestingPro analysis, the stock is currently trading above its Fair Value, placing it on the most overvalued list. The company’s performance has been noteworthy, as it continues to navigate the competitive landscape of the biotechnology sector. InvestingPro Tips highlight that three an…

Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com · May 5, 2026

The market expects MeiraGTx Holdings PLC (MGTX) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …

Latest earnings date

Mar 19, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: -$0.60

Revenue estimate: N/A

Market cap: $598.05M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Mar 19, 2026 2025-12-31 Time not specified -$0.60 N/A